The Food and Drug Administration has released some detailed information on adverse event reports related to several popular energy drinks.Read More »
An independent watch dog group has reported a 23.8 percent increase in the number of reports of serious adverse events associated with the use of various medications during the first quarter of 2012 as compared to the same time period ...Read More »
The anti-nausea drug Reglan and its generic counterparts were the drugs most frequently cited in litigation in 2011, according to a consumer watchdog’s latest analysis of Food and Drug Administration statistics.
Tagged with: Accutane adverse events Avandia Bayer Chantix Coumadin drug litigation FDA Food and Drug Administration GlaxoSmithKline Hoffman-LaRoche Institute for Safe Medication Practices Johnson & Johnson Levaquin Pfizer Pradaxa prescription drugs Reglan Wyeth Yasmin YazRead More »
A drug manufacturer had no duty to warn of the higher incidence of “adverse events” reported by those taking the company’s anti-cholesterol drug, a Pennsylvania appeals court has ruled in an unpublished decision affirming a defense verdict.Read More »